Mr. Marcos Agramont reports
ISODIOL INTERNATIONAL INC PROVIDES AN UPDATE ON THE DELAY IN FILING ITS AUDITED FINANCIAL STATEMENTS
Isodiol International Inc.
has provided an update on the delay on the filing of its audited annual financial statements, related management's discussion and analysis, and supporting officer certificates for the financial year ended March 31, 2019.
The company obtained a management cease trade order dated July 30, 2019, from the relevant securities regulators as contemplated by National Policy 12-203 (Management Cease Trade Orders) of the Canadian Securities Administrators.
The delay of the filings resulted from delays in the company obtaining access to accounting information following dispositions of subsidiaries, over which the company no longer has management influence. The company notes the audit is nearly complete and continues to expect to file the filings on or before Aug. 16, 2019.
The company will comply with the requirements of the alternative information guidelines set out in the National Policy. The company is not subject to any insolvency proceedings.
About Isodiol International Inc.
Isodiol International is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing and distribution company of hemp-based consumer packaged goods (CPG) and solutions. Isodiol has commercialized a greater-than-99-per-cent-pure, naturally isolated CBD (cannabidiol), including microencapsulations, and nanotechnology for quality consumable and topical skin care products. Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs and continued international expansion into Latin America, Asia and Europe.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.